The downgrade from Overweight to Neutral by Cantor Fitzgerald indicates a less optimistic outlook for Avantax. The lowering of the price target from $27 to $26 also suggests that the analyst sees less upside potential in the stock. This could potentially lead to a negative sentiment among investors, which may put downward pressure on the stock price in the short term.